Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.

American journal of obstetrics and gynecology - 1 Apr 2021

Chung Young Shin, Woo Ha Young, Lee Jung-Yun, Park Eunhyang, Nam Eun Ji, Kim Sunghoon, Kim Sang Wun, Kim Young Tae

Abstract excerpt

BACKGROUND: Patients younger than 40 years usually present with early-stage endometrial cancer with favorable prognosis. However, such patients are usually in their childbearing age and may desire fertility-sparing options. The identification of biomarkers may improve the clinical outcomes in these patients and aid in fertility-sparing management; however, there has been no reports on biomarker analysis so far....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to DNA Mismatch Repair

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Polymerase II

Share to Endometrial Neoplasms

Share to Endometrium

Share to Hysterectomy

Share to Neoplasm Recurrence, Local

Share to Receptors, Progesterone

Source

Identifiers

PMID: 33039397
DOI: 10.1016/j.ajog.2020.10.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.PMID 33039397Read ↗

Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer.Semantic proximity Read ↗

Molecular testing for endometrial cancer: An SGO clinical practice statement.Semantic proximity Read ↗

Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies.Semantic proximity Read ↗

Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection.Semantic proximity Read ↗

Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target TherapySemantic proximity Read ↗

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment DecisionsSemantic proximity Read ↗

An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach.Semantic proximity Read ↗

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments.Semantic proximity Read ↗

[Thoughts on the molecular characteristics of endometrial cancer in clinical diagnosis and treatment].Semantic proximity Read ↗

Molecular Characterization and Clinical Implications of Endometrial Cancer.Semantic proximity Read ↗

Molecular classification of endometrial carcinoma, is it the new era of precision medicine?Semantic proximity Read ↗

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.